VIMTALABS

Vimta Labs Limited

Contract research and testing laboratory for pharmaceuticals and food testing

Healthcare›Healthcare›Healthcare Services›Healthcare Research, Analytics & Technology

vimta.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹522.45
Market cap
2,334 Cr
Stock P/E
29.3
P/B
5.10
Dividend yield
0.2%
ROE (FY24)
12.8%
ROCE (FY24)
16.7%
Operating margin (FY24)
16.5%
Debt / equity (FY24)
0.06
OCF / EBITDA (FY26)
104.0%
OCF / EBITDA (3Y)
86.7%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Vimta Labs runs contract research and testing laboratories that serve pharmaceutical companies, food businesses and electronics and electrical manufacturers.

Company snapshot

4thBy market cap

Ranked among 5 companies in Healthcare Research, Analytics & Technology.

What we see

Positives
  • ✓Net margin of 19.6% — the business keeps a healthy share of every rupee it earns.
2 more signals from the filings.Sign in free to see them all

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales72 Cr80 Cr78 Cr80 Cr83 Cr89 Cr94 Cr98 Cr102 Cr99 Cr109 Cr109 Cr
Operating expenses (approx.)57 Cr59 Cr55 Cr57 Cr54 Cr56 Cr61 Cr64 Cr68 Cr64 Cr70 Cr72 Cr
EBITDA15 Cr21 Cr24 Cr24 Cr29 Cr32 Cr33 Cr34 Cr34 Cr34 Cr39 Cr37 Cr
OPM %21.2%26.1%30.2%29.4%34.8%36.5%35.0%34.5%33.6%34.7%36.0%34.2%
Other income2 Cr0.89 Cr0.49 Cr0.69 Cr0.68 Cr1 Cr2 Cr2 Cr3 Cr2 Cr3 Cr4 Cr
Interest0.61 Cr0.53 Cr0.53 Cr0.48 Cr0.41 Cr0.58 Cr0.44 Cr0.32 Cr0.37 Cr0.16 Cr0.32 Cr0.24 Cr
Depreciation9 Cr9 Cr8 Cr8 Cr8 Cr10 Cr9 Cr10 Cr10 Cr11 Cr13 Cr13 Cr
Profit before tax8 Cr13 Cr16 Cr16 Cr19 Cr28 Cr25 Cr25 Cr26 Cr23 Cr29 Cr28 Cr
Tax %24.5%24.9%24.1%25.7%23.9%25.3%26.8%25.2%24.2%24.8%27.3%25.7%
Net profit6 Cr9 Cr12 Cr12 Cr15 Cr21 Cr18 Cr19 Cr20 Cr18 Cr21 Cr21 Cr
EPS (₹)₹2.67₹4.26₹5.34₹5.25₹6.58₹9.44₹8.22₹4.25₹4.46₹3.96₹4.73₹4.71

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales154 Cr181 Cr213 Cr181 Cr209 Cr276 Cr315 Cr313 Cr344 Cr407 CrSign in free for the trailing twelve months
Operating expenses (approx.)127 Cr136 Cr155 Cr151 Cr156 Cr196 Cr222 Cr229 Cr222 Cr266 CrSign in free for the trailing twelve months
EBITDA27 Cr45 Cr58 Cr30 Cr53 Cr80 Cr94 Cr84 Cr122 Cr142 CrSign in free for the trailing twelve months
OPM %17.8%25.0%27.1%16.6%25.2%28.9%29.7%26.7%35.5%34.7%Sign in free for the trailing twelve months
Other income0.94 Cr1 Cr2 Cr3 Cr0.81 Cr1 Cr3 Cr4 Cr4 Cr9 CrSign in free for the trailing twelve months
Interest2 Cr5 Cr5 Cr4 Cr2 Cr1 Cr3 Cr2 Cr2 Cr1 CrSign in free for the trailing twelve months
Depreciation10 Cr16 Cr20 Cr21 Cr23 Cr23 Cr31 Cr34 Cr35 Cr44 CrSign in free for the trailing twelve months
Profit before tax17 Cr26 Cr35 Cr8 Cr28 Cr55 Cr64 Cr52 Cr90 Cr104 CrSign in free for the trailing twelve months
Tax %35.9%35.7%28.0%17.0%25.1%25.8%25.9%24.7%25.5%25.4%Sign in free for the trailing twelve months
Net profit11 Cr16 Cr25 Cr7 Cr21 Cr41 Cr47 Cr39 Cr67 Cr78 CrSign in free for the trailing twelve months
EPS (₹)₹4.79₹7.43₹11.45₹3.13₹9.62₹18.57₹21.37₹17.52₹30.28₹17.40Sign in free for the trailing twelve months
Dividend payout %————0.0%10.8%9.3%11.4%6.6%5.7%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital4 Cr4 Cr4 Cr4 Cr4 Cr4 Cr4 Cr4 Cr4 Cr9 Cr
Reserves132 Cr148 Cr167 Cr169 Cr190 Cr229 Cr276 Cr312 Cr374 Cr448 Cr
Borrowings37 Cr33 Cr17 Cr22 Cr22 Cr19 Cr15 Cr19 Cr9 Cr3 Cr
Other liabilities48 Cr48 Cr49 Cr49 Cr56 Cr54 Cr65 Cr61 Cr79 Cr102 Cr
Total liabilities222 Cr232 Cr237 Cr245 Cr273 Cr306 Cr360 Cr396 Cr467 Cr562 Cr
Fixed assets (net)88 Cr140 Cr135 Cr131 Cr128 Cr148 Cr156 Cr154 Cr224 Cr300 Cr
CWIP53 Cr—4 Cr2 Cr17 Cr0.31 Cr12 Cr59 Cr38 Cr18 Cr
Investments———6 Cr6 Cr6 Cr6 Cr6 Cr0 Cr2 Cr
Loans & advances———1 Cr2 Cr0.58 Cr0.32 Cr0.08 Cr0.08 Cr0.09 Cr
Inventories15 Cr15 Cr19 Cr17 Cr15 Cr17 Cr23 Cr25 Cr25 Cr30 Cr
Trade receivables42 Cr56 Cr59 Cr58 Cr73 Cr77 Cr80 Cr86 Cr106 Cr106 Cr
Cash & bank0.63 Cr2 Cr3 Cr5 Cr6 Cr11 Cr30 Cr12 Cr16 Cr23 Cr
Other assets22 Cr19 Cr18 Cr24 Cr26 Cr46 Cr54 Cr54 Cr58 Cr83 Cr
Total assets222 Cr232 Cr237 Cr245 Cr273 Cr306 Cr360 Cr396 Cr467 Cr562 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity24 Cr33 Cr39 Cr24 Cr37 Cr59 Cr87 Cr59 Cr95 Cr147 Cr
Cash from investing-39 Cr-24 Cr-16 Cr-20 Cr-32 Cr-38 Cr-57 Cr-75 Cr-76 Cr-130 Cr
Cash from financing13 Cr-8 Cr-23 Cr-1 Cr-5 Cr-16 Cr-11 Cr-2 Cr-17 Cr-10 Cr
Net cash flow-2 Cr1 Cr0.67 Cr3 Cr0.53 Cr5 Cr19 Cr-17 Cr2 Cr7 Cr
Free cash flow (OCF − Capex)-16 Cr9 Cr23 Cr10 Cr4 Cr20 Cr37 Cr-16 Cr15 Cr47 Cr

Ratios

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
ROCE %23.2%6.1%14.1%22.6%22.8%16.7%
ROE %14.8%4.0%11.0%17.7%17.1%12.8%
Debtor days10011712710192100
Inventory days1171179280112118
Days payable687293577139
Cash conversion cycle149162126124132179
OCF / EBITDA %—81.3%70.2%73.6%92.7%70.2%
OCF / EBITDA % (3 years)———73.9%80.7%79.4%
Debt / equity0.100.130.120.080.050.06
Current ratio2.131.672.052.602.862.91
Net debt / EBITDA0.000.590.320.11-0.160.07